DNA molecular recognition and cellular selectivity of anticancer metal(II) complexes of ethylenediaminediacetate and phenanthroline: Multiple targets

Journal of Biological Inorganic Chemistry

Volumn 17, Issue 1, 2012, Pages 57-69

  Von, Sze Tin ^a   Seng, Hoi Ling ^b   Lee, Hong Boon ^c   Ng, Seik Weng ^d   Kitamura, Yusuke ^e   Chikira, Makoto ^e   Ng, Chew Hee ^a  

^a UNIVERSITI TUNKU ABDUL RAHMAN   (Malaysia)

^b MALAYSIA UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Malaysia)

^c CANCER RESEARCH INITIATIVES FOUNDATION   (Malaysia)

^d UNIVERSITY OF MALAYA   (Malaysia)

^e CHUO UNIVERSITY   (Japan)

Author keywords

DNA binding specificity Restriction enzyme inhibition; Mitochondrial membrane potential; Topoisomerase I G quadruplex

Indexed keywords

1,10 PHENANTHROLINE; ANTINEOPLASTIC AGENT; CISPLATIN; COPPER COMPLEX; DNA TOPOISOMERASE; GUANINE QUADRUPLEX; N,N' ETHYLENEDIAMINEDICARBOXYLATE; UNCLASSIFIED DRUG; ZINC COMPLEX;

AMINO ACID SEQUENCE; ARTICLE; BINDING AFFINITY; BREAST CELL; CELL ACTIVITY; CELL CYCLE ARREST; CELL CYCLE S PHASE; CELL MEMBRANE CONDUCTANCE; CHEMICAL STRUCTURE; COMPLEX FORMATION; CONTROLLED STUDY; CRYSTAL STRUCTURE; DNA BINDING; DRUG CYTOTOXICITY; DRUG SELECTIVITY; ENZYME INHIBITION; ENZYME STABILITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; MOLECULAR RECOGNITION; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SINGLE STRANDED DNA BREAK; SYNTHESIS; X RAY CRYSTALLOGRAPHY;

ANTINEOPLASTIC AGENTS; CELL CYCLE; CELL PROLIFERATION; CRYSTALLOGRAPHY, X-RAY; DNA TOPOISOMERASES, TYPE I; DNA, NEOPLASM; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SCREENING ASSAYS, ANTITUMOR; ETHYLENEDIAMINES; G-QUADRUPLEXES; HUMANS; MODELS, MOLECULAR; ORGANOMETALLIC COMPOUNDS; PHENANTHROLINES; STRUCTURE-ACTIVITY RELATIONSHIP; SUBSTRATE SPECIFICITY; TUMOR CELLS, CULTURED;

EID: 84862565424     PISSN: 09498257     EISSN: 14321327     Source Type: Journal    
DOI: 10.1007/s00775-011-0829-0     Document Type: Article

References (81)

1. Gao EJ, Wang KH, Zhu MC, Liu L (2010) Eur J Med Chem 45:2784-2790
2. Klajner M, Hebraud P, Sirlin C, Gaiddon C, Harlepp S (2010) J Phys Chem B 114:14041-14047
3. Chen CY, Chen QZ, Wang XF, Liu MS, Chen YF (2009) Trans Met Chem 34:757-763
4. Wang P, Tang N (2009) J Fluoresc 19:1073-1082
5. Tan M, Zhu J, Pan Y, Chen Z, Liang H, Liu H, Wang H (2009) Bioinorg Chem Appl 2009:1-9
6. Casini A, Hartinger CG, Nazarov AA, Dyson PJ (2010) Topics Organomet Chem 32:57-80
7. Cinellu MA, Maiore L, Manassero M, Casini A, Arca M, Fiebig HH, Kelter G, Michelucci E, Pieraccini G, Gabbiani C, Messori L (2007) ACS Med Chem Lett 1:336-339
8. Pizarro AM, Habtemariam A, Sadler PJ (2010) Top Organomet Chem 32:21-56
9. Filak LK, Mühlgassner G, Jakupec MA, Heffeter P, Berger W, Arion VB, Keppler BK (2010) J Biol Inorg Chem 15:903-918
10. Tisato F, Marzano C, Porchia M, Pellei M, Santini C (2010) Med Res Rev 20:708-749
11. Xiao Y, Chen D, Zhang X, Cui Q, Fan Y, Bi C, Dou QP (2010) Int J Oncol 37:81-87
12. Olszewski U, Claffey J, Hogan M, Tacke M, Zeillinger R, Bednarski PJ, Hamilton G (2010) Invest New Drugs. doi 10.1007/s10637-010-9395-5
13. Bielawska A, Poplawska B, Surazyński A, Czarnomysy R, Bielawski K (2010) Eur J Pharmacol 643:34-41
14. Lo YC, Ko TP, Su WC, Su TL, Andrew Wang HJ (2008) J Inorg Biochem 103:1082-1092
15. Chen QY, Zhou DF, Huang J, Guo WJ, Gao J (2010) J Inorg Biochem 104:1141-1147
16. Pisani MJ, Weber DK, Heimann K, Collins JG, Keene FR (2010) Metallomics 2:393-396
17. Chen T, Liu Y, Zheng WJ, Liu J, Wong YS (2010) Inorg Chem 49:6366-6368
18. Jiang YL, Liu ZP (2010) Mini Rev Med Chem 10:726-736
19. Che CM, Siu FM (2010) Curr Opin Chem Biol 14:255-261
20. Ng CH, Kong KC, Von ST, Balraj P, Jensen P, Thirthagiri E, Hamada H, Chikira M (2008) Dalton Trans 36:447-454
21. Bruker (2007) APEX2 and SAINT. Bruker AXS, Madison
22. Sheldrick GM (1996) SADABS. University of Göttingen, Germany
23. Sheldrick GM (1997) SHELXS 97 program for crystal structure solution. University of Göttingen, Germany
24. Sheldrick GM (1997) SHELXL-97 program for crystal structure refinement. University of Göttingen
25. Farrugia LJ (1997) J Appl Crystallogr 30:565
26. Seng HL, Von ST, Tan KW, Maah MJ, Ng SW, Raja Abd Rahman RNZ, Caracelli I, Ng CH (2010) Biometals 23:99-118
27. Shi LM, Fan Yi, Lee JK, Waltham M, Andrews DT, Scherf U, Paull KD, Weinstein JN (2000) J Chem Inf Comput Sci 40:367-379
28. Gajewski E, Gaur S, Akman SA, Matsumoto L, van Balgooy JNA, Doroshow JH (2007) Biochem Pharm 73:1947-1956
29. Seng HL, Alan Ong HK, Raja Abd Rahman RNZ, Yamin BM, Tiekink ERT, Tan KW, Maah MJ, Caracelli I, Ng CH (2008) J Inorg Biochem 102:1997-2011
30. Chin LF, Kong SM, Seng HL, Kong KhooKS, Vikneswaran R, Teoh SG, Ahmad M, Alan Khoo SB, Maah MJ, Ng CH (2011) J Inorg Biochem 105:221-229
31. Tasa E, Kilic A, Durgun M, Kupecik L, Yilmaz I, Arslan S (2010) Spectrochim Acta A 75:811-818
32. Yu H, Wang X, Fu M, Ren J, Qu X (2008) Nucleic Acids Res 36:5695-5703
33. Agarwal T, Roy S, Chakraborty TK, Maiti S (2010) Biochemistry 49:8388-8397
34. Nagesh N, Krishnaiah A (2003) J Biochem Biophys Methods 57:65-74
35. Talib J, Green C, Davis KJ, Urathamakul T, Beck JL, Aldrich-Wright JR, Ralph SF (2008) Dalton Trans 37:1018-1026
36. Gomez D, Wenner T, Brassart B, Douarre C, O'Donohue MF, El Khoury V, Shin-Ya K, Morjani H, Trenstesaux C, Riou JF (2006) J Biol Chem 281:38721-38729
37. Tauchi T, Shin-ya K, Sashida G, Sumi M, Okabe S, Ohyashiki JH, Ohyashiki K (2006) Oncogene 25:5719-5725
38. Phatak P, Cookson JC, Dai F, Smith V, Gartenhaus RB, Stevens MF, Burger AM (2007) Br J Cancer 96:1223-1233
39. Gowan SM, Harrison JR, Patterson L, Valenti M, Read MA, Neidle S, Kelland LR (2002) Mol Pharmacol 61:1154-1162
40. Tsai YC, Qi H, Lin CP, Lin RK, Kerrigan JE, Rzuczek SG, Lavoie EJ, Rice JE, Pilch DS, Lisa Lyu Y, Liu LF (2009) J Biol Chem 34:22535-22543
41. Sunani S, Nishimura T, Nishimura I, Ito S, Arakawa H, Ohkubo M (2009) J Med Chem 52:3225-3237
42. Rothenberg ML (1997) Ann Oncol 8:837-855
43. Beretta GL, Perego P, Zunino F (2008) Expert Opin Ther Targets 12:1243-1256
44. Teicher BA (2008) Biochem Pharmacol 75:1262-1271
45. Pommier Y (2008) Nat Rev Cancer 18:789-802
46. Reinhold WC, Mergny J-L, Liu H, Ryan M, Pfister TD, Kinders R, Parchment R, Doroshow J, Weinstein JN, Pommier Y (2010) Cancer Res 70:2191-2203
47. Arimondo PB, Riou JF, Mergny JL (2000) Nucl Acids Res 28:4832-4838
48. Marchand C, Pourquier P, Laco GS, Jing N, Pommier Y (2002) J Biol Chem 277:8906-8911
49. Sun RWY, Li CKL, Ma DL, Yan JJ, Lok C-N, Leung CH, Zhu N, Che CM (2010) Chem Eur J 16:3097-3113
50. Salvioli S, Ardizzoni A, Cossarizza A, Franceschi C (1997) FEBS Lett 411:72-82
51. Cossarizza A, Baccarani CM, Kalashnikova G, Franceschi C (1993) Biochem Biophs Res Commun 197:40-45
52. Hada H, Honda C, Tanemura H (1977) Photogr Sci Eng 21:83-91
53. Reers M, Smith TW, Chen LB (1991) Biochemistry 30:4480-4486
54. Smiley ST, Reers M, Hartshorn CM, Lin M, Chen A, Smith TW, Steele GD, Chen LB (1991) ProcNatlAcad Sci USA 88:3671-3675
55. Cossarizza A (2000) Miner Biotechnol 12:57-61
56. Debatin K-M (2000) Toxicol Lett 112-113:41-48
57. Meggers E, Atilla-Gokcumen GE, Gründler K, Frias C, Prokop A (2009) Dalton Trans 38:10882-10888
58. Mulcahy SP, Gründler K, Frias G, Wagner L, Prokop A, Meggers E (2010) Dalton Trans 39:8177-8182
59. Kachadourian R, Brechbuhl HM, Ruiz-Azuara L, Gracia-Mora I, Day BJ (2010) Toxicology 268:176-183
60. Jung J-Y, Kim W-J (2004) Neurosci Lett 371:85-90
61. Dineley KE, Richards LL, Votyakova TV, Reynolds JJ (2005) Mitochondria 5:55-65
62. Krumschnabel G, Manzl C, Berger C, Hofer B (2005) Toxicol Appl Pharmacol 209:62-73
63. Ostrakhovitch EA, Cherian MG (2005) Apoptosis 10:111-121
64. Starha P, Trávn?́c?k Z, Popa I (2009) J Inorg Biochem 103:978-988
65. Trávn?́c?k Z, Klanicová A, Popa I, Rolc?ik J (2005) J Inorg Biochem 99:776-786
66. Kovala-Demertzi D, Yadav PN, Wiecek J, Skoulika S, Varadinova T, Demertzis MA (2006) J Inorg Biochem 100:1558-1567
67. Malon? M, Trávn?́c?k Z (2002) Trans Met Chem 27:580-586
68. Arjmand F, Muddassir M (2010) J Photochem Photobiol B Biol 101:37-46
69. Chashoo G, Singh SK, Sharma PR, Mondhe DM, Hamid A, Saxena A, Andotra SS, Shah BA, Qazi NA, Taneja SC, Saxena AK (2011) Chem Biol Interact 189:60-71
70. Neidle S (2010) FEBS J 277:1118-1125
71. Grem JL, Danenberg KD, Behan K, Parr A, Young L, Danenberg PV, Nguyen D, Drake J, Monks A, Allegra CJ (2001) Clin Cancer Res 7:999-1009
72. Boyd MR (2004) In Teicher B, Andrews PA (eds) Drug development guide: preclinical screening, clinical trials, and approval. 2nd edn. Humana, New Jersey, pp 41-61
73. Carter SK (1984) In Hacker MP (eds) Platinum coordination complexes in cancer chemotherapy. Martinus Nijhoff Press, Boston pp 359-365
74. Keppler BK (1993) Metal complexes in cancer therapy. VCH, Weinheim, pp 1-15
75. von Hoff DD, Schilsky R, Reichert CM, Reddick RL, Rozencweig M, Young RC, Muggia FM (1979) Cancer Treat Rep 63:1527-1535
76. El-Ghannam A, Ricci K, Malkawi A, Jahed K, Vedantham K, Wyan H, Allen LD, Dréau D (2010) J Mater Sci Mater Med 21:2701-2710
77. Meyer L, Patte-Mensah C, Taleb O, Mensah-Nyagan AG (2011) Pain 152:170-181
78. Capranico G, Binaschi M, Borgnetto ME, Zunino F, Palumbo M (1997) Trends Pharmacol Sci 18:323-329
79. Rao VA, Agama K, Holbeck S, Pommier Y (2007) Cancer Res 67:9971-9979
80. Arimondo PB, Thomas CJ, Oussedik K, Baldeyrou B, Mahieu C, Halby L, Guianvarc'h D, Lansiaux A, Hecht SM, Bailly C, Giovannangeli C (2006) Mol Cell Biol 26:324-333
81. Jänicke RU (2008) Breast Cancer Res Treat 117:219-221